Literature DB >> 12972972

Delorme's procedure for rectal prolapse: clinical and physiological analysis.

Akira Tsunoda1, Naokuni Yasuda, Noboru Yokoyama, Goichi Kamiyama, Mitsuo Kusano.   

Abstract

PURPOSE: Clinical and physiological results of Delorme's procedure were assessed retrospectively in patients undergoing this procedure for rectal prolapse.
METHODS: A consecutive series of 31 patients (7 males, 24 females; age, 14-93, mean 70 years) with full-thickness, rectal prolapse were treated by Delorme's procedure between 1994 and 2002. Median follow-up was 39 (range, 6-96) months.
RESULTS: Good results were achieved in 27 patients (87 percent), prolapse recurrence was observed in 4 (13 percent), and mean recurrence time was 14 (range, 3-25) months. There were no postoperative deaths. Minor complications occurred in four patients. The median changes in preoperative and postoperative physiologic patterns in 16 patients were as follows: resting pressure from 21.0 (range, 5-48) to 23.5 (range, 12-76) cm H2O (P = 0.030), squeeze pressure from 64.0 (range, 27-248) to 108.0 (range, 32-264) cm H2O (P = 0.041), volume at first sensation from 100 (range, 70-180) to 70 (range, 40-130) ml (P = 0.002), maximum tolerated volume from 260 (range, 120-400) to 160 (range, 70-400) ml (P = 0.001). Incontinence improved in 63 percent. No patient became constipated, and 38 percent of those constipated preoperatively improved. The preoperative incontinence score improved from 11.5 (range, 1-20) to 6.0 (range, 0-20) after operation (P < 0.0001).
CONCLUSION: Delorme's procedure had a low morbidity, did not lead to constipation, improved anal continence, and had a reasonably low recurrence rate. Improved anal sphincter and rectal sensation were associated with a reduced incidence of defecatory problems after Delorme's procedure.

Entities:  

Mesh:

Year:  2003        PMID: 12972972     DOI: 10.1007/s10350-004-6724-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  18 in total

1.  [Rectal prolapse in adults].

Authors:  W Heitland
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

2.  Rectal prolapse: which surgical option is appropriate?

Authors:  T H K Schiedeck; O Schwandner; J Scheele; S Farke; H-P Bruch
Journal:  Langenbecks Arch Surg       Date:  2004-03-05       Impact factor: 3.445

3.  Delorme's Procedure for Full-Thickness Rectal Prolapse; Does it Alter Anorectal Function.

Authors:  Sabry A Mahmoud; Waleed Omar; Kamal Abdel-Elah; Mohamed Farid
Journal:  Indian J Surg       Date:  2012-01-07       Impact factor: 0.656

4.  Rectal prolapse.

Authors:  David P O'Brien
Journal:  Clin Colon Rectal Surg       Date:  2007-05

Review 5.  Consensus Statement of the Italian Society of Colorectal Surgery (SICCR): management and treatment of complete rectal prolapse.

Authors:  G Gallo; J Martellucci; G Pellino; R Ghiselli; A Infantino; F Pucciani; M Trompetto
Journal:  Tech Coloproctol       Date:  2018-12-15       Impact factor: 3.781

6.  Evaluation of Clinical Outcomes after Abdominal Rectopexy and Delorme's Procedure for Rectal Prolapse: A Prospective Study.

Authors:  Hemanth Makineni; Poornachandra Thejeswi; B K Shivprasad Rai
Journal:  J Clin Diagn Res       Date:  2014-05-15

7.  Optimizing Treatment for Rectal Prolapse.

Authors:  Jennifer Hrabe; Brooke Gurland
Journal:  Clin Colon Rectal Surg       Date:  2016-09

8.  Delorme's Procedure for Complete Rectal Prolapse: Does It Still Have It's Own Role?

Authors:  Sooho Lee; Bong-Hyeon Kye; Hyung-Jin Kim; Hyeon-Min Cho; Jun-Gi Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-02-29

9.  Short-term results after STARR versus internal Delorme for obstructed defecation: a non-randomized prospective study.

Authors:  N L Ohazuruike; J Martellucci; C Menconi; S Panicucci; G Toniolo; G Naldini
Journal:  Updates Surg       Date:  2014-01-16

10.  Prolapse of the rectum, long-term results of surgical treatment.

Authors:  Anders T Hoel; Arne Skarstein; Kjell K Ovrebo
Journal:  Int J Colorectal Dis       Date:  2008-09-13       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.